Class information for:
Level 1: MAGNESIUM SULFATE//ECLAMPSIA//MAGNESIUM SULPHATE

Basic class information

ID Publications Average number
of references
Avg. shr. active
ref. in WoS
10525 989 28.0 60%



Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)



ID, lev.
above
Publications Label for level above
477 14988 PRE ECLAMPSIA//HYPERTENSION IN PREGNANCY//HELLP SYNDROME

Terms with highest relevance score



Rank Term Type of term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 MAGNESIUM SULFATE Author keyword 53 28% 16% 161
2 ECLAMPSIA Author keyword 34 21% 14% 141
3 MAGNESIUM SULPHATE Author keyword 9 22% 4% 38
4 LATE POSTPARTUM ECLAMPSIA Author keyword 4 75% 0% 3
5 POSTPARTUM PREECLAMPSIA Author keyword 4 75% 0% 3
6 MAGNESIUM SULFATE TOCOLYSIS Author keyword 3 100% 0% 3
7 POSTPARTUM ECLAMPSIA Author keyword 3 60% 0% 3
8 IONIZED MAGNESIUM Author keyword 2 15% 1% 14
9 MAGNESIUM SULFATE MGSO4 Author keyword 2 67% 0% 2
10 MAGPIE TRIAL OFF Address 2 67% 0% 2

Web of Science journal categories

Author Key Words



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
LCSH search Wikipedia search
1 MAGNESIUM SULFATE 53 28% 16% 161 Search MAGNESIUM+SULFATE Search MAGNESIUM+SULFATE
2 ECLAMPSIA 34 21% 14% 141 Search ECLAMPSIA Search ECLAMPSIA
3 MAGNESIUM SULPHATE 9 22% 4% 38 Search MAGNESIUM+SULPHATE Search MAGNESIUM+SULPHATE
4 LATE POSTPARTUM ECLAMPSIA 4 75% 0% 3 Search LATE+POSTPARTUM+ECLAMPSIA Search LATE+POSTPARTUM+ECLAMPSIA
5 POSTPARTUM PREECLAMPSIA 4 75% 0% 3 Search POSTPARTUM+PREECLAMPSIA Search POSTPARTUM+PREECLAMPSIA
6 MAGNESIUM SULFATE TOCOLYSIS 3 100% 0% 3 Search MAGNESIUM+SULFATE+TOCOLYSIS Search MAGNESIUM+SULFATE+TOCOLYSIS
7 POSTPARTUM ECLAMPSIA 3 60% 0% 3 Search POSTPARTUM+ECLAMPSIA Search POSTPARTUM+ECLAMPSIA
8 IONIZED MAGNESIUM 2 15% 1% 14 Search IONIZED+MAGNESIUM Search IONIZED+MAGNESIUM
9 MAGNESIUM SULFATE MGSO4 2 67% 0% 2 Search MAGNESIUM+SULFATE+MGSO4 Search MAGNESIUM+SULFATE+MGSO4
10 PREVENTION OF CEREBRAL PALSY 2 67% 0% 2 Search PREVENTION+OF+CEREBRAL+PALSY Search PREVENTION+OF+CEREBRAL+PALSY

Key Words Plus



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 PREMAG TRIAL 23 100% 1% 10
2 TOTAL PEDIATRIC MORTALITY 10 47% 2% 16
3 PROTECT INFANT BRAIN 9 83% 1% 5
4 SULFATE TREATMENT 8 75% 1% 6
5 MILD PREECLAMPSIA 8 50% 1% 11
6 HYPERMAGNESEMIA 8 27% 2% 24
7 PARENTERAL MAGNESIUM SULFATE 6 100% 0% 4
8 PEDIATRIC MORTALITY 5 63% 1% 5
9 CA1 NEURONAL DEATH 4 67% 0% 4
10 PHENYTOIN PROPHYLAXIS 4 75% 0% 3

Journals

Reviews



Title Publ. year Cit. Active
references
% act. ref.
to same field
Global and regional estimates of preeclampsia and eclampsia: a systematic review 2013 24 3 67%
Magnesium sulphate and other anticonvulsants for women with pre-eclampsia 2010 24 45 91%
Antenatal magnesium sulfate and neuroprotection 2012 11 17 82%
Magnesium Is Not Consistently Neuroprotective for Perinatal Hypoxia-Ischemia in Term-Equivalent Models in Preclinical Studies: A Systematic Review 2014 3 54 74%
Is survival and neurodevelopmental impairment at 2 years of age the gold standard outcome for neonatal studies? 2015 2 12 25%
Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus 2009 75 43 49%
Magnesium sulfate therapy in preeclampsia and eclampsia 1998 77 32 88%
Lessons for low-income regions following the reduction in hypertension-related maternal mortality in high-income countries 2011 20 26 42%
A systematic review of maternal and infant outcomes following magnesium sulfate for pre-eclampsia/eclampsia in real-world use 2012 10 18 56%
Magnesium sulphate versus phenytoin for eclampsia 2010 13 32 66%

Address terms



Rank Address term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ.
in class
1 MAGPIE TRIAL OFF 2 67% 0.2% 2
2 AUSTRALIAN HLTH WOMEN BABIES 2 26% 0.6% 6
3 OURCE RANDOMISED TRIALS 2 43% 0.3% 3
4 NEUROSURG NEUROMUSCULAR NEUROL DISORDE 1 100% 0.2% 2
5 PEDIAT CLIN PROGRAM 1 33% 0.2% 2
6 BGU CANC 1 23% 0.3% 3
7 BIO MED MED 1 50% 0.1% 1
8 BUR INT CORP 1 50% 0.1% 1
9 CAMBODIA MATERNAL CHILD HLTH PROJECT 1 50% 0.1% 1
10 FLOATING HOSP CHILDREN NEWBORN MED 1 50% 0.1% 1

Related classes at same level (level 1)



Rank Relatedness score Related classes
1 0.0000216553 TOCOLYSIS//RITODRINE//ATOSIBAN
2 0.0000184254 CHRONIC HYPERTENSION//CLINICAL AND EXPERIMENTAL HYPERTENSION PART B-HYPERTENSION IN PREGNANCY//LABETALOL
3 0.0000167757 ANAESTHETIC TECHNIQUES REGIONAL INTRATHECAL//IONS POTASSIUM CHLORIDE//PHARMACOLOGY MAGNESIUM SULPHATE LIGNOCAINE
4 0.0000141980 PHYSIOPATHOL IMPLANTAT DEV//PLACENTAL VESSELS//N ACETYLHOMOTAURINATE
5 0.0000125120 MAGNESIUM-BULLETIN//MAGNESIUM RESEARCH//MAGNESIUM DEFICIENCY
6 0.0000123366 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME//REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME//HYPERTENSIVE ENCEPHALOPATHY
7 0.0000093442 HELLP SYNDROME//ACUTE FATTY LIVER OF PREGNANCY//ACUTE FATTY LIVER
8 0.0000082160 NNOSI//7 NINA//NUCLEAR CA2 INFLUX
9 0.0000079255 OCULAR CHANGES//ELSCHNIGS SPOTS//ANTI GLAUCOMA MEDICATION
10 0.0000072478 CLINICAL AND EXPERIMENTAL HYPERTENSION PART B-HYPERTENSION IN PREGNANCY//PREECLAMPSIA PREVENTION//LOW DOSE ASPIRIN